Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Cash from Investing Activities (2017 - 2023)

Updated

Avenue Therapeutics' Cash from Investing Activities was -$3 million in FY2023.

Analysis

Avenue Therapeutics (ATXI) Cash from Investing Activities (2017 - 2023) Analysis & Trends

From FY2015 onward, Avenue Therapeutics has reported Cash from Investing Activities for 5 years.

  • The FY2023 figure marks the highest annual Cash from Investing Activities since FY2020.
  • Per Business Quant data, Cash from Investing Activities in earlier years was -$1 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -2.71 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -1.20 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.11 Bn
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -1.00 Mn
Mar 31, 2020 -1.00 Mn
Dec 31, 2019 5.00 Mn
Jun 30, 2019 -5.00 Mn
Mar 31, 2018 10.00 Mn
Sep 30, 2017 -10.00 Mn
API Access

Avenue Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ATXI&period=max&api_key=YOUR_API_KEY